BT
Better Therapeutics, Inc.
BTTX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.45K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor ROA 173.30%
Asset turnover 0.00x
ROIC 273.72%
Debt
64 /100
Moderate Int. coverage -25.66x
Net debt/EBITDA 0.02x
Current ratio 1.37x
Stability
1 /100
Unstable EPS volatility 167.43%
Profitable years 0
Beta 0.19x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BTTX
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Craig R. Jalbert
Employees
54
Headquarters
San Francisco
Evenimente viitoare
12 NOV.
Earnings
Upcoming earnings report